Biomedical Excellence for Safer Transfusion Colaborative

Analysis

Biomedical Excellence for Safer Transfusion Colaborative is a registered charity in United States, based in Canada. It received its IRS tax-exemption ruling in November 2005, 21 years ago. Its declared purposes cover science and technology, which this site groups under arts, culture, heritage and science. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Biomedical Excellence for Safer Transfusion Colaborative reported income of $330k and spending of $395k, spending 120% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $466k to $330k (-29%), an average of -8.2% a year. The sharpest change came in the year to December 2021, when income rose by 64%. Over the whole period it spent 79% of the income it received.

Among 45,478 United States charities whose main cause is arts, culture, heritage and science and that reported income, Biomedical Excellence for Safer Transfusion Colaborative sits at the 70th percentile: it is larger than about 70% of them. Against every charity in United States with reported income it ranks in the 63rd percentile. Charities of a similar size with the same main cause include High Five Access Media ($330k), Baton Rouge Blues Foundation ($330k) and Equinox Theatre Company ($330k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% and program service revenue 0.0% of the total. Compensation of current officers, directors and key employees was $120k (30% of expenses). At year end it held assets of $837k against liabilities of $0, net assets of $837k.